For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
If you continue without changing your cookie settings, we'll assume you’re happy with this.
If incorrect, please enter your country/region into the box below, to view site information related to your country/region.
Don't have an account?
Custom antibody development and commercial partnerships to advance your diagnostic and therapeutic discovery.
Create custom solutions with us
Partner with us
Access advice and support for any research roadblock
View support hub
Your experiments laid out step by step
Full event breakdown with abstracts, speakers, registration and more
View global event calendar
View all pathways
View all interactive pathways
Compare our top recombinant PD-L1 antibody clones.
The PD-1/PD-L1 pathway has shown promising clinical success as a cancer immunotherapy target. Learn how this pathway may lead to the next breakthrough.
Find the antibodies and assay kits you need to unlock the power of immuno-oncology. Includes products for PD-L1, PD-1, CTLA4 and CXCR4.
Highly characterized in IHC, Flow Cyt and ICC/IF and knockout (KO) validated.